CHM Cannabis
Home > Boards > US Listed > Biotechs >

Portola Phramaceuticals (PTLA)

PTLA RSS Feed
Add PTLA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/17/2018 3:25:59 AM - Followers: 26 - Board type: Free - Posts Today: 0

Additional discussion of PTLA, its competitors,
and the industries in which it operates may be
found on the Biotech Values board.


PTLA Investor Relations

CHM Cannabis
PTLA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PTLA News: Statement of Changes in Beneficial Ownership (4) 11/16/2018 05:33:56 PM
PTLA News: Quarterly Report (10-q) 11/07/2018 04:46:54 PM
PTLA News: Current Report Filing (8-k) 11/07/2018 04:14:44 PM
PTLA News: Portola Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update 11/07/2018 04:05:00 PM
PTLA News: Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences 11/06/2018 04:30:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#151   I would not be surprised if there is Valsartan160 11/17/18 03:25:59 AM
#150   A couple of notes from the CC: H2R 11/08/18 12:10:24 PM
#149   From the PR H2R 11/07/18 09:59:29 PM
#148   was this a key day? Valsartan160 10/31/18 12:21:49 AM
#147   Cerdulatinib Orphan Drug Designation H2R 09/25/18 05:53:07 PM
#146   PTLA hires CEO—former CEO at RLYP: DewDiligence 09/20/18 11:49:57 AM
#145   "Potential to Cause a Sharp Upward Move in H2R 09/14/18 02:04:31 PM
#144   PAS Date: December 31, 2018. H2R 09/11/18 06:43:47 PM
#142   Why the PAS matters: H2R 08/31/18 10:17:42 AM
#141   Jeffrey Bird Buys in August: H2R 08/31/18 10:01:43 AM
#140   Submits PAS for broad Andexxa commercial launch H2R 08/31/18 09:52:28 AM
#139   2Q18 Bevyxxa sales=$33K (not a typo). The skepticism DewDiligence 08/28/18 03:49:15 PM
#138   PTLA: $100M milestone payment! H2R 05/24/18 03:30:07 PM
#137   SoS on approval: H2R 05/04/18 01:14:47 PM
#136   Thanks DD :) H2R 05/04/18 10:09:48 AM
#135   PTLA—FDA approves Andexxa—an antidote to bleeding caused by DewDiligence 05/04/18 04:28:58 AM
#134   Within one week of PDUFA on Andexanet Alpha H2R 04/30/18 03:28:01 AM
#133   BMY-JNJ collaboration could be bad for PTLA, if DewDiligence 04/16/18 05:03:43 PM
#132   Within one month now PDUFA on Andexanet Alpha H2R 04/05/18 05:21:58 PM
#131   Yes, it was baked in because it was DewDiligence 03/23/18 10:16:30 AM
#130   It looks like that was baked in the H2R 03/23/18 10:12:43 AM
#129   CHMP rejects Betrixaban (as expected): DewDiligence 03/23/18 09:05:18 AM
#128   Today's PR from ACC: DewDiligence 03/12/18 02:30:22 PM
#127   Why PTLA is selling off a little more DewDiligence 03/12/18 02:29:25 PM
#126   Buy Zeroze2002 03/12/18 02:27:16 PM
#125   Prediction from 5 years ago appears to be DewDiligence 02/28/18 05:28:03 PM
#124   CHMP likely to reject Betrixaban MAA: #msg-138699767. DewDiligence 02/20/18 07:01:01 PM
#123   PTLA -4%/AH—PDUFA date for Bevyxxa CMC issue delayed DewDiligence 11/21/17 06:30:29 PM
#122   PTLA sells 7.30M* shares @$55.00—a 1% discount to DewDiligence 09/13/17 09:18:36 AM
#121   PTLA CC—Bevyxxa launch delayed until Nov 2017—and possibly DewDiligence 09/05/17 04:44:19 PM
#120   PTLA holding CC to discuss Bevyxxa “launch plans” DewDiligence 09/04/17 08:03:28 PM
#119   AndexXa BLA resubmission has PDUFA date of 2/2/18: DewDiligence 08/15/17 09:07:07 AM
#118   PTLA buy 62.18 stocktrademan 07/13/17 02:28:55 PM
#117   Maybe they think the stock is a tad DewDiligence 07/02/17 07:09:45 PM
#116   Do have any ideas why the heavy insiders GD 07/02/17 01:40:18 PM
#115   Four insiders sold cumulative $25M of stock since DewDiligence 07/01/17 04:56:39 PM
#114   Super active today! StephanR90 06/23/17 01:53:53 PM
#113   PTLA had $318.8M cash at 12/31/16—expects $290-310M cash DewDiligence 02/28/17 07:24:54 PM
#112   Little more room I think for higher prices jones99 02/21/17 05:44:12 AM
#111   Ah ok thanks, so I'm gonna read the Radar_Mi 02/10/17 07:08:26 PM
#110   Each case has to be considered on its DewDiligence 02/10/17 07:07:02 PM
#109   Hi, This is a comment of an institutional broker Radar_Mi 02/10/17 06:54:29 PM
#108   I consider the lack of an advisory panel DewDiligence 02/09/17 08:12:50 PM
#107   Portola Pharmaceuticals Inc (NASDAQ:PTLA) Just Scored Twice In trendmkr 02/09/17 01:37:59 PM
#106   DD, valid point and agreed. But, why doingmybest 01/05/17 12:42:24 PM
#105   For approval based on a single phase-3 trial, DewDiligence 01/05/17 10:23:08 AM
#104   DD, you are basing the FDA rejection on doingmybest 01/05/17 09:51:31 AM
#103   Actually, the opposite. I expect the FDA not DewDiligence 01/04/17 08:00:48 PM
#102   I presume you are thinking Betrixiban PDUFA in doingmybest 01/04/17 07:58:02 PM
#101   One approval this year is more likely than DewDiligence 01/04/17 05:38:56 PM
PostSubject